Official announcements
Search narrowed by
messages in brief
|
01/10/2013
Many medicinal products, when stored appropriately, remain in compliance with their specifications for much longer than can be expected on the basis of their expiration date. If you want to use such stocks of medicinal products safely and…
Safety warnings
|
messages in brief
|
26/07/2013
Metoclopramide-containing medicinal products are approved in a number of Member States in various indications, including nausea and vomiting (for example, after chemotherapy or radiotherapy, surgery, or for migraine) and gastrointestinal motility…
messages in brief
|
25/07/2013
Please note the new account number of the Federal Office for Safety in Health Care (BASG) / AGES Medizinmarktaufsicht: BAWAG P.S.K. AG IBAN: AT59 6000 0000 9605 1496 BIC: OPSKATWW DVR: 2112611 Inquiries: E-mail: qmgt@ages.at
Safety warnings
|
messages in brief
|
28/06/2013
Ergot derivatives (various preparations)
messages in brief
|
27/06/2013
More than 100 countries participated in this year's week of action against the illegal sale of medicines on the Internet. In total, more than nine million potentially dangerous medicines worth around 41 million US dollars were seized worldwide.…
messages in brief
|
26/06/2013
Please note that, with effect from 1 July 2013, product information texts should be submitted via the PHAROS eService "Marketing Authorisation & Lifecycle Management of Medicines" on https://eservices.basg.gv.at . By then, texts and documents are no…
messages in brief
|
26/06/2013
As of 02.07.2013, new regulations apply to the import of active ingredients for medicinal products for human use into the European Union. As of this date, active substances for medicinal products for human use may only be imported if at least one of…
Safety warnings
|
messages in brief
|
18/04/2013
Methotrexate (various preparations)
messages in brief
|
18/04/2013
As of 01.07.2013, the transmission of Austrian product information texts is to take place via the eService "Marketing Authorization and Lifecycle Drug Specialties ". The e-mail address spc@ages.at will no longer be available as of 31.01.2014. With…
messages in brief
|
14/02/2013
If there are major differences in the measurement of pharmacokinetic parameters, such as the AUC or Cmax, after repeated administration of the identical drug, it is reasonable to suspect that the specific product or the active ingredient itself could…